Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region.

Alsaadi, Taoufik; Almadani, Abubaker; Al-Hashel, Jasem; Al Salti, Abdullah; Melikyan, Gayane; Khan, Riaz Ahmed

Alsaadi, Taoufik; Almadani, Abubaker; Al-Hashel, Jasem; Al Salti, Abdullah; Melikyan, Gayane; Khan, Riaz Ahmed.

Afiliação

Alsaadi T; Neurology Department, American Center for Psychiatry and Neurology, Abu Dhabi, UAE. talsaadi@live.ca.
Almadani A; Neurology Department, Rashid Hospital, Dubai, UAE.
Al-Hashel J; Department of Medicine, Kuwait University, Kuwait City, Kuwait.
Al Salti A; Neurology Department, Khoula Hospital, Muscat, Oman.
Melikyan G; Neurology, Weill Cornell Medical College-Qatar (WCMC-Q), Ar-Rayyan, Qatar.
Khan RA; Ibn Sina Hospital, Kuwait, Kuwait.

Neurol Ther ; 12(4): 1015-1031, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37222860

Palavras-chave

Anti-seizure medication; Consensus; Drug substitution; Epilepsy; Gulf

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Neurol Ther Ano de publicação: 2023 Tipo de documento: Article País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google